MK0767 and Metformin Combination Study (0767-028)

Merck Sharp & Dohme LLC0 个研究点目标入组 114 人开始时间: 2003年6月最近更新: 2015年6月17日

适应症

试验速览

阶段: 3 期
状态: 终止
发起方: Merck Sharp & Dohme LLC
入组人数: 114

研究概览研究设计入排标准研究者记录与标识符相似试验

研究概览

简要总结

A study to test the effects of MK0767 when added to Metformin in patients with inadequately controlled Type 2 Diabetes Mellitus.

This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

研究设计

研究类型: Interventional
分配方式: Randomized
干预模型: Parallel
主要目的: Treatment
盲法: Double (Participant, Investigator)

入排标准

年龄范围: 21 Years 至 78 Years（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•All women of childbearing potential must have a negative urine pregnancy test prior to starting the study
•Patients must be on a stable dose of metformin for at least 2 weeks prior to visit 2

排除标准

•Patients with a history of type 1 diabetes mellitus and/or history of ketoacidosis
•Patients on estrogen replacement therapy regimen or SERM
•Patients with history of, allergy to, intolerance or hypersensitivity to statins or fibric acid derivatives, including history of elevated muscle and liver function tests, jaundice, hepatoxicity, or myopathy associated with these treatments
•Patient is on a weight loss program with ongoing weight loss or starting an intensive exercise program within 4 weeks from starting the study
•Have active liver or gall bladder disease
•HIV positive

研究者

发起方

Merck Sharp & Dohme LLC

申办方类型

Industry

责任方

Sponsor

相似试验

终止

3 期

Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)Diabetes Mellitus, Type 2

NCT00543361Merck Sharp & Dohme LLC382

终止

3 期

MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)Diabetes Mellitus, Type 2

NCT00543816Merck Sharp & Dohme LLC100

终止

3 期

MK0767 and Sulfonylurea Combination Study (0767-027)Diabetes Mellitus, Type 2

NCT00543491Merck Sharp & Dohme LLC129

尚未招募

1 期

Metformin as a chemotherapeutic agent

IRCT20220409054463N1Shahid Beheshti University of Medical Sciences40

已完成

3 期

HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes MellitusDiabetes Mellitus, Type 2

NCT04564872Sichuan Haisco Pharmaceutical Group Co., Ltd465